Want to see IN:AMBUJACEM full AI Analyst Report?
AMBUJACEM Stock Chart & Stats
₹424.95
₹4.85(1.14%)
At close: 4:00 PM EDT
₹424.95
₹4.85(1.14%)
Day’s Range― - ―
52-Week Range₹394.00 - ₹615.00
Previous CloseN/A
Volume1.14M
Average Volume (3M)850.88K
Market Cap
₹1.07T
Enterprise Value₹1.12M
Total Cash (Recent Filing)₹9.59B
Total Debt (Recent Filing)₹8.66B
Price to Earnings (P/E)24.4
Beta1.07
Next Earnings
Feb 03, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.46%
Share Statistics
EPS (TTM)18.58
Shares Outstanding2,484,817,100
10 Day Avg. Volume35,629
30 Day Avg. Volume850,878
Financial Highlights & Ratios
PEG Ratio1.66
Price to Book (P/B)1.67
Price to Sales (P/S)2.45
P/FCF Ratio-123.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹470.00Price Target Upside10.60% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)10.23
Revenue Forecast (FY)₹437.84B
Bulls Say, Bears Say
Bulls Say
Low Leverage & Strong EquityAmbuja's very low leverage and a materially larger equity base provide durable financial flexibility. This balance-sheet strength supports sustained capital spending, weathering cyclical demand, and prioritizing strategic investments without relying heavily on external debt, preserving long-term optionality and resilience.
Sustained Revenue GrowthA multi-year uptrend in revenue, culminating in ~13.9% growth in 2026, signals structurally stronger demand and market share stability. Persistent top-line expansion supports higher plant utilization, absorbs fixed costs, and creates a basis for long-term margin recovery if cost pressures are managed effectively.
Improved Net Income & ROENet income recovery to ~47.3B and healthy ROE levels indicate the company can convert sales into shareholder returns despite a growing capital base. This suggests operational capability to generate profits at scale, which is important for sustainable reinvestment and long-term capital allocation.
Bears Say
Margin CompressionEBITDA and EBIT declining while revenue rose points to structural margin pressure from higher input, logistics costs, or competitive pricing. If sustained, weaker operating margins reduce cash conversion, constrain reinvestment capacity, and can erode ROE unless cost structure or pricing power is restored.
Volatile Cash GenerationErratic OCF and repeated negative free cash flow across several years indicate uneven cash conversion driven by investment cycles or working capital swings. Persistent FCF volatility limits the company's ability to consistently fund dividends, deleverage, or pursue M&A without external financing.
EPS PressureA notable decline in EPS growth (about -18.3%) reflects pressure on per-share profitability, potentially from margin erosion or equity base expansion. Continued EPS weakness can undermine shareholder returns and signals the need for operational improvements to restore earnings per share growth.
Ambuja Cements Limited News
AMBUJACEM FAQ
What was Ambuja Cements Limited’s price range in the past 12 months?
Ambuja Cements Limited lowest stock price was ₹394.00 and its highest was ₹615.00 in the past 12 months.
What is Ambuja Cements Limited’s market cap?
Ambuja Cements Limited’s market cap is ₹1.07T.
When is Ambuja Cements Limited’s upcoming earnings report date?
Ambuja Cements Limited’s upcoming earnings report date is Feb 03, 2027 which is in 184 days.
How were Ambuja Cements Limited’s earnings last quarter?
Currently, no data Available
Is Ambuja Cements Limited overvalued?
According to Wall Street analysts Ambuja Cements Limited’s price is currently Undervalued.
Does Ambuja Cements Limited pay dividends?
Ambuja Cements Limited pays a Annually dividend of ₹2 which represents an annual dividend yield of 0.46%. See more information on Ambuja Cements Limited dividends here
What is Ambuja Cements Limited’s EPS estimate?
Ambuja Cements Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ambuja Cements Limited have?
Ambuja Cements Limited has 2,484,817,100 shares outstanding.
What happened to Ambuja Cements Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Ambuja Cements Limited?
Currently, no hedge funds are holding shares in IN:AMBUJACEM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Ambuja Cements Limited
Ambuja Cements Limited, including its subsidiaries, is a leading Indian entity engaged in the production and sale of cement and related building materials. The company serves a diverse customer base throughout India, targeting individual homeowners, masons, contractors, architects, and engineers. Its product portfolio encompasses Portland pozzolana cement, ordinary Portland cement, temperature-resistant concrete blocks, Blaine Portland cement, and various micro-materials. These products are distributed via an extensive network that includes dealers, authorized retail stockists, general retailers, and authorized sales representatives. Established in 1981 and based in Mumbai, India, the firm was formerly known as Gujarat Ambuja Cements Limited, adopting its current name in April 2007. Ambuja Cements Limited operates as a subsidiary of Holderind Investments Ltd.
AMBUJACEM Stock 12 Month Forecast
Average Price Target
₹470.00
▲(10.60% Upside)
Technical Analysis
ACC Limited
―
Dalmia Bharat Ltd.
―
Shree Cement Limited
―
UltraTech Cement Limited
―
JSW Cement Limited
―